Trial intelligence / Profile preview

Efficacy of Fermented Papaya Preparation on Markers of Systemic Inflammation

NCT02051634Phase 1Completed

Sponsor
University of Florida
Start
Oct 2014
Primary completion
Dec 2016
Countries
1
01

Overview

Phase 1, randomised, double-blind trial (2 arms), sponsored by University of Florida. Primary endpoints: Interleukin-6 at 20 weeks, Tumor necrosis factor-alpha at 20 weeks and 2 more. Started Oct 2014; status: completed.

Beyond the preview

Go deeper on NCT02051634.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02051634.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call